CKD-M2研究:对于晚期病的2年死亡率预测工具
Dung N T Tran1,2, Yves Dimitrov3, Francois Chantrel4
1Laboratoire de Biométrie et Biologie Évolutive, UMR 5558 CNRS Lyon, Université Claude Bernard Lyon 1, Villeurbanne, 69100, France.
BMC nephrology
|December 25, 2025
概括
这项研究改善了预测慢性病 (CKD) 患者2年死亡率的工具. 增强预测工具在外部验证中表现出令人满意的表现,有助于对CKD死亡风险的临床决策.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物统计学 生物统计学
- 医疗信息学 医疗信息学
背景情况:
- 预测慢性病全因死亡率的现有模型往往缺乏可靠的方法和外部验证.
- 这项研究解决了在晚期CKD阶段 (4-5) 需要可靠的预测工具的需求.
研究的目的:
- 增强以前经过验证的贝叶斯网络工具,用于预测4-5期慢性结核病患者2年全因死亡率.
- 通过扩大培训数据集和第二次外部验证来提高该工具的稳定性和通用性.
主要方法:
- 在一个扩展的国家数据集上训练了贝叶斯网络模型,其中包含了先前外部验证的数据.
- 内部验证使用了10倍交叉验证;对CERRENE队列进行了外部验证.
- 性能指标包括精度,AUC-ROC,灵敏度和特异性;校准使用校准曲线和Brier分数进行了评估.
主要成果:
- 该预测工具是使用1061名患者开发的,并对409名CKD 4-5期患者进行了验证.
- 观察到令人满意的内部和外部验证性能:准确度 (77.2%与77.8%相比),AUC-ROC (0.76与0.74).
- 外部验证显示灵敏度为54.2%,特异性为82.3%,校准可接受 (布赖尔分数 = 0.132).
结论:
- 更新的贝叶斯网络预测工具在内部和外部验证方面表现出令人满意的表现.
- 在广泛临床实施之前,需要进一步的国家和国际外部验证.
- 该工具对改善晚期CKD的风险分层和临床决策充满希望.
相关概念视频
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
166
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
166
01:25Chronic Kidney Disease I: Introduction
536
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
536
01:28Chronic Kidney Disease III: Interprofessional Care
319
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
319
01:29Acute Kidney Injury III: Clinical Manifestations
763
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
763
01:22Acute Kidney Injury I: Introduction
511
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
511
01:24Chronic Kidney Disease II: Clinical Manifestations
520
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520